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Background
Anakinra is effective in a subgroup of SoJIA patients
Aim
To analyze the long-term follow-up of Anakinra-treated
patients
Methods
34 SoJIA patients (19 M, 15 F) were treated with Ana-
k i n r aa tt h es t a r i n gd o s eo f1m g / k g / d i e .C o m p l e t e
response: no clinical and laboratory activity in absence
of other treatments; partial response: active disease
despite anakinra; no responders: withdraw of Anakinra
due to inefficacy.
Results
The mean follow-up was 4.02 year (range 1.05 - 6.16).
At the last follow-up 13 patients were complete respon-
ders, 5 partial responders and 16 non responder.
Among complete responders, 4 patients withdrawn
Anakinra without relapses after a mean of 3 years of
treatment, 7 are in remission using anakinra only, 2
patients were switched to anti IL-1 monoclonal antibody
with a full response. Despite the good control of their
disease 11/13 displayed at least one relapse of their dis-
ease during the follow-up with a total of 22 relapses
(range 1-4 for patient).
Among partial responders two patients were pre-
viously considered as complete responders. In 16 non
responders patients subsequent treatments were canaki-
numab (1 pt), tocilizumab (5 patients), or combined
immunosuppressive treatment and/or anti-TNF (10 pts).
Two non-responders patients died. Responders patients
confimed to have an higher number of active joints at
baseline (p = 0.006) and higher WBC and neutrhophils
c o u n t( p=0 . 0 0 2 ) .N e w l ye n r o l l e dr e s p o n d e rp a t i e n t s
has a significantly shorter disease duration in respect to
non responder patients (p = 0.03).
Conclusions
Anakinra response still dissect two distinct populations
of SoJIa patients
Published: 14 September 2011
doi:10.1186/1546-0096-9-S1-P158
Cite this article as: Gattorno et al.: Long-term follow-up of systemic
onset juvenile idiopathic arthritis patients treated with Anakinra.
Pediatric Rheumatology 2011 9(Suppl 1):P158.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit 2nd Division of Pediatrics, “G. Gaslini” Institute, Genoa, Italy
Gattorno et al. Pediatric Rheumatology 2011, 9(Suppl 1):P158
http://www.ped-rheum.com/content/9/S1/P158
© 2011 Gattorno et al; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.